P2Y2 receptor deficiency aggravates chronic kidney disease progression

Frontiers in Physiology

Volumn 4 SEP, Issue , 2013, Pages

  Potthoff, Sebastian A ^a   Stegbauer, Johannes ^a   Becker, Jan ^b   Wagenhaeuser, P Johannes ^c   Duvnjak, Blanka ^a   Rump, Lars C ^a   Vonend, Oliver ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adenosine triphosphate (ATP); Chronic kidney disease; P2Y2 receptor; Purinercic receptors; Subtotal nephrectomy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATININE; CYCLOOXYGENASE 1; IMMUNOGLOBULIN KAPPA CHAIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN E SYNTHASE; PURINERGIC P2Y2 RECEPTOR; RNA 18S; TRANSFORMING GROWTH FACTOR BETA1; UREA;

18S GENE; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; COX1 GENE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DISEASE EXACERBATION; DNA SYNTHESIS; GENE; GENE EXPRESSION; GENE TARGETING; GLOMERULUS EPITHELIUM; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY MASS; MALE; MCP1 GENE; MOUSE; NEPHRECTOMY; NF KAPPA B GENE; NONHUMAN; PAI 1 GENE; PGSE1 GENE; PROTEIN DEFICIENCY; PURINERGIC P2Y2 RECEPTOR DEFICIENCY; SHAM PROCEDURE; SYSTOLIC BLOOD PRESSURE; TGF BETA 1 GENE; TISSUE INJURY; UPREGULATION; UREA BLOOD LEVEL; URINE VOLUME;

EID: 84884548654     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00234     Document Type: Article

References (54)

1. Abbracchio, M. P., Burnstock, G., Boeynaems, J. M., Barnard, E. A., Boyer, J. L., Kennedy, C., et al. (2006). International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58, 281-341. doi: 10.1124/pr.58.3.3
2. Alperovich, G., Maldonado, R., Moreso, F., Fulladosa, X., Grinyo, J. M., and Seron, D. (2004). Glomerular enlargement assessed by paired donor and early protocol renal allograft biopsies. Am. J. Transplant. 4, 650-654. doi: 10.1111/j.1600-6143.2004.00392.x
3. Bailey, M. A., Hillman, K. A., and Unwin, R. J. (2000). P2 receptors in the kidney. J. Auton. Nerv. Syst. 81, 264-270. doi: 10.1016/S0165-1838(00)00125-9
4. Booth, J. W., Tam, F. W., and Unwin, R. J. (2012). P2 purinoceptors: renal pathophysiology and therapeutic potential. Clin. Nephrol. 78, 154-163. doi: 10.5414/CN107325
5. Brecht, H. M., Ernst, W., and Koch, K. M. (1976). Plasma noradrenaline levels in regular haemodialysis patients. Proc. Eur. Dial Transplant Assoc. 12, 281-290.
6. Burnstock, G. (1995). Noradrenaline and ATP: cotransmitters and neuromodulators. J. Physiol. Pharmacol. 46, 365-384.
7. Burnstock, G. (2006). Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27, 166-176. doi: 10.1016/j.tips.2006.01.005
8. Burnstock, G. (2012). Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. Bioessays 34, 218-225. doi: 10.1002/bies.201100130
9. Burnstock, G., and Knight, G. E. (2004). Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304. doi: 10.1016/S0074-7696(04)40002-3
10. Buvinic, S., Briones, R., and Huidobro-Toro, J. P. (2002). P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br. J. Pharmacol. 136, 847-856. doi: 10.1038/sj.bjp.0704789
11. 2 receptor. Biochem. Pharmacol. 82, 1126-1133. doi: 10.1016/j.bcp.2011.07.094
12. da Silva, C. G., Specht, A., Wegiel, B., Ferran, C., and Kaczmarek, E. (2009). Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 119, 871-879. doi: 10.1161/CIRCULATIONAHA.108.764571
13. 2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells. J. Immunol. 183, 4521-4529. doi: 10.4049/jimmunol.0803977
14. Gerasimovskaya, E. V., Ahmad, S., White, C. W., Jones, P. L., Carpenter, T. C., and Stenmark, K. R. (2002). Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J. Biol. Chem. 277, 44638-44650. doi: 10.1074/jbc. M203012200
15. Gourine, A. V., Wood, J. D., and Burnstock, G. (2009). Purinergic signalling in autonomic control. Trends Neurosci. 32, 241-248. doi: 10.1016/j.tins.2009.03.002
16. Harada, H., Chan, C. M., Loesch, A., Unwin, R., and Burnstock, G. (2000). Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int. 57, 949-958. doi: 10.1046/j.1523-1755.2000.00911.x
17. Hoch, H., Stegbauer, J., Potthoff, S. A., Hein, L., Quack, I., Rump, L. C., et al. (2011). Regulation of renal sympathetic neurotransmission by renal alpha(2A)- adrenoceptors is impaired in chronic renal failure. Br. J. Pharmacol. 163, 438-446. doi: 10.1111/j.1476-5381.2011.01223.x
18. Homolya, L., Watt, W. C., Lazarowski, E. R., Koller, B. H., and Boucher, R. C. (1999). Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor(-/-) mice. J. Biol. Chem. 274, 26454-26460. doi: 10.1074/jbc.274.37.26454
19. Hoy, W. E., Douglas-Denton, R. N., Hughson, M. D., Cass, A., Johnson, K., and Bertram, J. F. (2003). A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int. Suppl. 63, S31-S37. doi: 10.1046/j.1523-1755.63.s83.8.x
20. Kalinski, P. (2012). Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21-28. doi: 10.4049/jimmunol.1101029
21. Kotanko, P. (2006). Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood Purif. 24, 95-99. doi: 10.1159/000089444
22. Lan, H. Y., and Chung, A. C. (2012). TGF-beta/Smad signaling in kidney disease. Semin. Nephrol. 32, 236-243. doi: 10.1016/j.semnephrol.2012.04.002
23. Luttikhuizen, D. T., Harmsen, M. C., de Leij, L. F., and van Luyn, M. J. (2004). Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res. 317, 289-298. doi: 10.1007/s00441-004-0939-x
24. Ma, L. J., and Fogo, A. B. (2003). Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 64, 350-355. doi: 10.1046/j.1523-1755.2003.00058.x
25. Mailloux, L. U. (2001). Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes. Semin. Nephrol. 21, 146-156. doi: 10.1053/snep.2001.20949
26. Marrelli, S. P. (2001). Mechanisms of endothelial P2Y(1)- and P2Y(2)-mediated vasodilatation involve differential [Ca2+]i responses. Am. J. Physiol. Heart Circ. Physiol. 281, H1759-H1766.
27. Masuo, K., Lambert, G. W., Esler, M. D., Rakugi, H., Ogihara, T., and Schlaich, M. P. (2010). The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens. Res. 33, 521-528. doi: 10.1038/hr.2010.35
28. Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., et al. (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375, 2073-2081. doi: 10.1016/S0140-6736(10)60674-5
29. Oberg, B. P., McMenamin, E., Lucas, F. L., McMonagle, E., Morrow, J., Ikizler, T. A., et al. (2004). Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 65, 1009-1016. doi: 10.1111/j.1523-1755.2004.00465.x
30. Oberhauser, V., Vonend, O., and Rump, L. C. (1999). Neuropeptide Y and ATP interact to control renovascular resistance in the rat. J. Am. Soc. Nephrol. 10, 1179-1185.
31. O'Mullane, L. M., Cook, D. I., and Dinudom, A. (2009). Purinergic regulation of the epithelial Na+ channel. Clin. Exp. Pharmacol. Physiol. 36, 1016-1022. doi: 10.1111/j.1440-1681.2009.05256.x
32. 2 receptor tone. J. Biol. Chem. 283, 36599-36607. doi: 10.1074/jbc. M807129200
33. 2-receptor tone. FASEB J. 24, 2056-2065. doi: 10.1096/fj.09-151506
34. Potthoff, S. A., Sitek, B., Stegbauer, J., Schulenborg, T., Marcus, K., Quack, I., et al. (2008). The glomerular proteome in a model of chronic kidney disease. Proteomics Clin. Appl. 2, 1127-1139. doi: 10.1002/prca.200800010
35. Ralevic, V., and Burnstock, G. (1991). Roles of P2-purinoceptors in the cardiovascular system. Circulation 84, 1-14. doi: 10.1161/01.CIR.84.1.1
36. Ralevic, V., and Burnstock, G. (2003). Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect. 16, 133-140. doi: 10.1358/dnp.2003.16.3.876886
37. 2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells. Cell Calcium 49, 240-248. doi: 10.1016/j.ceca.2011.02.008
38. 2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. FASEB J. 21, 3717-3726. doi: 10.1096/fj.07-8807com
39. Rieg, T., Gerasimova, M., Boyer, J. L., Insel, P. A., and Vallon, V. (2011). P2Y(2) receptor activation decreases blood pressure and increases renal Na(+) excretion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R510-R518. doi: 10.1152/ajpregu.00148.2011
40. Rumberger, B., Vonend, O., Kreutz, C., Wilpert, J., Donauer, J., Amann, K., et al. (2007). cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain. Kidney Blood Press. Res. 30, 377-387. doi: 10.1159/000108624
41. Rump, L. C., Amann, K., Orth, S., and Ritz, E. (2000). Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia. Nephrol. Dial. Transplant. 15, 1735-1738. doi: 10.1093/ndt/15.11.1735
42. Suliman, M., and Stenvinkel, P. (2008). Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi. J. Kidney Dis. Transpl. 19, 329-345. Available online at: http://www.sjkdt.org/text.asp?2008/19/3/329/40491
43. Turner, C. M., Vonend, O., Chan, C., Burnstock, G., and Unwin, R. J. (2003). The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 175, 105-117. doi: 10.1159/000073754
44. Unwin, R. J., Bailey, M. A., and Burnstock, G. (2003). Purinergic signaling along the renal tubule: the current state of play. News Physiol. Sci. 18, 237-241.
45. U.S. Renal Data System (USRDS). (2011). Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
46. Vonend, O., Grote, T., Oberhauser, V., Von Kugelgen, I., and Rump, L. C. (2003). P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway. Br. J. Pharmacol. 139, 1119-1126. doi: 10.1038/sj.bjp.0705358
47. Vonend, O., Oberhauser, V., Von Kugelgen, I., Apel, T. W., Amann, K., Ritz, E., et al. (2002). ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney Int. 61, 1617-1626. doi: 10.1046/j.1523-1755.2002.00315.x
48. Vonend, O., Rump, L. C., and Ritz, E. (2008). Sympathetic overactivity-the Cinderella of cardiovascular risk factors in dialysis patients. Semin. Dial. 21, 326-330. doi: 10.1111/j.1525-139X.2008.00456.x
49. Vonend, O., Stegbauer, J., Sojka, J., Habbel, S., Quack, I., Robaye, B., et al. (2005). Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney. Br. J. Pharmacol. 145, 66-74. doi: 10.1038/sj.bjp.0706151
50. Waldherr, R., and Gretz, N. (1988). Natural course of the development of histological lesions after 5/6 nephrectomy. Contrib. Nephrol. 60, 64-72.
51. Wan, J., Ristenpart, W. D., and Stone, H. A. (2008). Dynamics of shear-induced ATP release from red blood cells. Proc. Natl. Acad. Sci. U.S.A. 105, 16432-16437. doi: 10.1073/pnas.0805779105
52. 2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations. Am. J. Physiol. Renal Physiol. 285, F711-F721. doi: 10.1152/ajprenal.00096.2003
53. Yamamoto, K., Furuya, K., Nakamura, M., Kobatake, E., Sokabe, M., and Ando, J. (2011). Visualization of flow-induced ATP release and triggering of Ca2+ waves at caveolae in vascular endothelial cells. J. Cell Sci. 124, 3477-3483. doi: 10.1242/jcs.087221
54. Young, J. H., Klag, M. J., Muntner, P., Whyte, J. L., Pahor, M., and Coresh, J. (2002). Blood pressure and decline in kidney function: findings from the systolic hypertension in the elderly program (SHEP). J. Am. Soc. Nephrol. 13, 2776-2782. doi: 10.1097/01.ASN.0000031805.09178.37